Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 4, 2011, Pages 529-536

  Kim, Junghyun ^a   Kim, Chan Sik ^a   Sohn, Eunjin ^a   Jeong, Il Ha ^a   Kim, Hyojun ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Advanced glycation end products; Apoptosis; Diabetic keratopathy

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT; CASPASE 3; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORNEA EDEMA; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; CORNEA STROMA; CORNEA THICKNESS; DIABETES MELLITUS; DIABETIC KERATOPATHY; DNA DAMAGE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KERATOPATHY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CORNEAL DISEASES; CORNEAL STROMA; DEOXYGUANOSINE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, CORNEAL; EPITHELIUM, CORNEAL; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79955595448     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1573-9     Document Type: Article

References (47)

1. Robertson RP (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279:42351-42354
2. Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167-178
3. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK (1992) Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol 110:537-540
4. Friend J, Ishii Y, Thoft RA (1982) Corneal epithelial changes in diabetic rats. Ophthalmic Res 14:269-278 (Pubitemid 12042127)
5. Taylor HR, Kimsey RA (1981) Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci 20:548-553 (Pubitemid 11007359)
6. Brightbill FS, Myers FL, Bresnick GH (1978) Postvitrectomy keratopathy. Am J Ophthalmol 85:651-655 (Pubitemid 8323912)
7. Foulks GN, Thoft RA, Perry HD, Tolentino FI (1979) Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol 97:1076-1078 (Pubitemid 9187833)
8. Goebbels M, Spitznas M (1991) Endothelial barrier function after phacoemulsification: a comparison between diabetic and nondiabetic patients. Graefes Arch Clin Exp Ophthalmol 229:254-257
9. Perry HD, Foulks GN, Thoft RA, Tolentino FI (1978) Corneal complications after closed vitrectomy through the pars plana. Arch Ophthalmol 96:1401-1403
10. Kaji Y, Usui T, Oshika T, Matsubara M, Yamashita H, Araie M, Murata T, Ishibashi T, Nagai R, Horiuchi S, Amano S (2000) Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 41:362-368 (Pubitemid 30080435)
11. Yucel I, Yucel G, Akar Y, Demir N, Gurbuz N, Aslan M (2006) Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Can J Ophthalmol 41:60-66
12. Ahmed N (2005) Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 67:3-21
13. Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234
14. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241-2248 (Pubitemid 34729031)
15. Kaji Y, Amano S, Usui T, Oshika T, Yamashiro K, Ishida S, Suzuki K, Tanaka S, Adamis AP, Nagai R, Horiuchi S (2003) Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 44:521-528 (Pubitemid 36159694)
16. Kasper M, Roehlecke C, Witt M, Fehrenbach H, Hofer A, Miyata T, Weigert C, Funk RH, Schleicher ED (2000) Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. Am J Respir Cell Mol Biol 23:485-491
17. Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z (2002) Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem Biophys Res Commun 296:877-882
18. Sady C, Khosrof S, Nagaraj R (1995) Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Commun 214:793-797
19. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S (1992) Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214
20. Marion MS, Carlson EC (1994) Immunoelectron microscopic analyses of Maillard reaction products in bovine anterior lens capsule and Descemet's membrane. Biochim Biophys Acta 1191:33-42 (Pubitemid 24133526)
21. Gul M, Emre S, Esrefoglu M, Vard N (2008) Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats. Cornea 27:795-801
22. Sohn EJ, Kim CS, Kim YS, Jung DH, Jang DS, Lee YM, Kim JS (2007) Effects of magnolol (5, 5′-diallyl-2, 2′-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto - Kakizaki rats. Life Sci 80:468-475 (Pubitemid 46013908)
23. Kim J, Kim CS, Sohn E, Kim H, Jeong IH, Kim JS (2010) Lens epithelial cell apoptosis initiates diabetic cataractogenesis in the Zucker diabetic fatty rat. Graefes Arch Clin Exp Ophthalmol 248:811-818
24. Sato E, Mori F, Igarashi S, Abiko T, Takeda M, Ishiko S, Yoshida A (2001) Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diab Care 24:479-482 (Pubitemid 32198416)
25. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44:129-146 (Pubitemid 32156196)
26. Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151 (Pubitemid 24090096)
27. Alves M, Calegari VC, Cunha DA, Saad MJ, Velloso LA, Rocha EM(2005) Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats. Diabetologia 48:2675-2681 (Pubitemid 41738237)
28. Roszkowska AM, Tringali CG, Colosi P, Squeri CA, Ferreri G (1999) Corneal endothelium evaluation in type I and type II diabetes mellitus. Ophthalmologica 213:258-261 (Pubitemid 29331690)
29. Take G, Karabay G, Erdogan D, Duyar I (2006) The ultrastructural alterations in rat corneas with experimentally-induced diabetes mellitus. Saudi Med J 27:1650-1655
30. Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M (2002) Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction. Free Radic Biol Med 33:236-247 (Pubitemid 34775195)
31. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740-31749
32. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901 (Pubitemid 29375048)
33. Beckman KB, Ames BN (1997) Oxidative decay of DNA. J Biol Chem 272:19633-19636 (Pubitemid 27340047)
34. Klocek MS, Sassani JW, McLaughlin PJ, Zagon IS (2007) Topically applied naltrexone restores corneal reepithelialization in diabetic rats. J Ocul Pharmacol Ther 23:89-102 (Pubitemid 46642150)
35. Kowluru RA (2005) Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci 76:1051-1060
36. Yanagiya N, Akiba J, Kado M, Yoshida A, Kono T, Iwamoto J (1997) Transient corneal edema induced by nitric oxide synthase inhibition. Nitric Oxide 1:397-403 (Pubitemid 28076547)
37. Pepose JS, Ubels JL (1992) The cornea. In: Hart WM Jr (ed) Adler's physiology of the eye. Mosby, St. Louis, pp 53-58
38. Waring GO 3rd, Bourne WM, Edelhauser HF, Kenyon KR (1982) The corneal endothelium. Normal and pathologic structure and function. Ophthalmology 89:531-590
39. Wigham CG, Guggenheim JA, Hodson SA (1994) Sodium movement into and out of corneal endothelium. Pflugers Arch 428:577-582 (Pubitemid 24321877)
40. Agardh CD, Stenram U, Torffvit O, Agardh E (2002) Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J Diabetes Complications 16:395-400 (Pubitemid 35449085)
41. Nicholls K, Mandel TE (1989) Advanced glycosylation endproducts in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 60:486-491 (Pubitemid 19141796)
42. Osicka TM, Yu Y, Panagiotopoulos S, Clavant SP, Kiriazis Z, Pike RN, Pratt LM, Russo LM, Kemp BE, Comper WD, Jerums G (2000) Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes 49:87-93 (Pubitemid 30022928)
43. Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972-3978
44. Peponis V, Papathanasiou M, Kapranou A, Magkou C, Tyligada A, Melidonis A, Drosos T, Sitaras NM (2002) Protective role of oral antioxidant supplementation in ocular surface of diabetic patients. Br J Ophthalmol 86:1369-1373 (Pubitemid 35408638)
45. Kalfa TA, Gerritsen ME, Carlson EC, Binstock AJ, Tsilibary EC (1995) Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci 36:2358-2367
46. Moore TC, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB, Adamis AP (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 44:4457-4464 (Pubitemid 37186283)
47. Stitt AW, Moore JE, Sharkey JA, Murphy G, Simpson DA, Bucala R, Vlassara H, Archer DB (1998) Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Vis Sci 39:2517-2523 (Pubitemid 28558209)